查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1871899

桦木酸市场预测至2032年：按来源、形态、纯度、应用、最终用户和地区分類的全球分析

Betulinic Acid Market Forecasts to 2032 - Global Analysis By Source (Natural Source and Synthetic Source), Form, Purity, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 预测，2025 年全球桦木酸市场价值将达到 1 亿美元，预计到 2032 年将达到 3.3 亿美元。

预计在预测期内，桦木酸的复合年增长率将达到17.7%。桦木酸是一种天然的五环三萜类化合物，主要存在于桦树皮和多种药用植物中。它具有多种治疗作用，包括抗癌、抗病毒、抗菌和抗发炎特性。其作用机转包括诱导癌细胞凋亡、抑制病毒增生、对抗氧化伤害。由于其生物活性和广泛的药理潜力，桦木酸在未来的药物研究和临床应用方面具有巨大的前景。

全球癌症发生率不断上升

随着肿瘤学研究的活性化，天然抗癌物质因其治疗潜力而备受关注。桦木酸因其对癌细胞的选择性细胞毒性而闻名，目前正被越来越多地用于临床应用和作为膳食补充剂。人口老化和诊断技术的进步推动了对标靶癌症治疗的需求。製药和膳食补充剂生产商正加大对植物来源分子的研发投入，以期开发出能够辅助传统治疗方法的药物，预计这一趋势将加速桦木酸在癌症预防和治疗领域的应用。

原料取得困难

季节性收穫週期和地理限制制约了产量原材料的取得。确保永续的原材料来源仍然是一项挑战，尤其对于那些寻求扩大生产规模的製造商而言更是如此。围绕森林砍伐和生物多样性保护的监管压力进一步加剧了原材料采购的复杂性。小规模生产商在确保可靠的供应链方面面临成本障碍和物流挑战。这些限制可能会减缓市场扩张，并增加对合成替代品的依赖。

合成和萃取技术的进步

绿色化学方法和酵素技术在提高产量和纯度的同时，也降低了对环境的影响。研究人员正在开发可扩展的生物技术工艺，以克服原材料的限制。这些创新降低了生产成本，并扩大了其商业应用范围。改进的萃取通讯协定也促进了这些技术在药物製剂和机能性食品中的应用。随着技术的成熟，预计它将推动市场成长并扩大其可及性。

来自合成替代品的竞争

具有相似药理特性的合成类似物的出现对天然桦木酸构成了竞争威胁。这些实验室设计的化合物通常具有更高的均一性、扩充性和更清晰的监管规定。由于核准流程简化和成本优势，製药公司可能会优先考虑合成方案。药物化学的进步使得设计更有效的衍生物成为可能，这些衍生物能够模拟桦木酸的抗癌特性。这种转变可能导致对天然资源的投资减少，从而威胁到植物萃取物的市场份额。如果缺乏明确的差异化，天然桦木酸可能难以在高价值应用领域保持其地位。

新冠疫情的影响：

疫情扰乱了全球供应链，导致桦木酸的采购和生产计画延误。封锁和劳动力短缺影响了采伐和加工作业，尤其是在森林资源丰富的地区。然而，这场危机也间接刺激了需求，激发了人们对具有免疫支持和抗病毒特性的化合物的兴趣。疫情也促进了对桦木酸抗病毒特性的研究，包括其在新冠肺炎辅助性治疗中的作用。后疫情时代的策略强调供应链韧性和植物活性成分来源多角化。

预计在预测期内，天然成分细分市场将占据最大的市场份额。

由于其安全性、生物利用度以及消费者对植物来源成分的偏好，预计天然来源成分将在预测期内占据最大的市场份额。桦木酸植物来源，因其抗炎和抗癌特性，成为膳食补充剂和化妆品的热门成分。监管机构正透过洁净标示倡议和传统医学框架，日益支持天然化合物。製造商正投资于永续采收和可追溯性，以满足不断增长的需求。人们对天然疗法和整体健康理念的日益重视，也使这一细分市场受益匪浅。

预计在预测期内，营养补充品公司板块的复合年增长率将最高。

预计在预测期内，营养保健品领域将实现最高成长率，这主要得益于消费者对预防保健和功能性补充剂日益增长的兴趣。各公司正将桦木酸添加到旨在免疫力、消炎和预防癌症的产品中。洁净标示运动和对植物来源活性成分的需求正在推动胶囊、粉剂和饮料领域的创新。与植物萃取物生产商和研究机构的策略合作正在加速产品开发。监管部门对营养保健品的支持正在帮助产品更快进入市场并拓展分销管道。

占比最大的地区：

亚太地区预计将在预测期内占据最大的市场份额，这主要得益于其丰富的生物多样性、不断完善的医疗基础设施以及对传统药物的强劲需求。中国、印度和韩国等国正在加大对植物药研发的投入。政府主导的各项措施正在推动草药成分融入主流医疗保健和膳食补充剂中。该地区的生产能力和成本优势为桦木酸的大规模生产提供了支持。癌症发生率的上升以及消费者对天然疗法的偏好正在推动市场成长。

预计年复合成长率最高的地区：

由于北美拥有强大的研发生态系统和植物来源源疗法，预计该地区在预测期内将实现最高的复合年增长率。美国和加拿大正在增加对天然核准药物和功能性成分的投资。监管机构正在简化植物药和膳食补充剂的审批流程。意识提升，推动了对桦木酸等生物活性化合物的需求。提取技术和产品形式的创新正在扩大市场渗透率。

免费客製化服务：

购买此报告的客户可享有以下免费自订选项之一：

  • 公司概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 主要企业SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 原始研究资料
    • 次级研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球桦木酸市场（按原始材料划分）

  • 介绍
  • 天然来源
  • 合成来源

6. 全球桦木酸市场（依形态划分）

  • 介绍
  • 粉末
  • 液体
  • 胶囊

7. 全球桦木酸市场（依纯度划分）

  • 介绍
  • 纯度：98%或以上
  • 纯度低于98%

8. 全球桦木酸市场（依应用领域划分）

  • 介绍
  • 製药
    • 抗癌药物
    • 抗爱滋病毒药物
    • 抗发炎药
  • 化妆品和个人护理
    • 抗衰老产品
    • 肌肤修復配方
  • 食品和营养补充剂
    • 营养补充品
    • 机能性食品
  • 化学和研究应用
  • 其他用途

9. 全球桦木酸市场（以最终用户划分）

  • 介绍
  • 製药公司
  • 化妆品製造商
  • 实验室
  • 营养补充品公司
  • 其他最终用户

10. 全球桦木酸市场（依地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与併购
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十二章：企业概况

  • Thermo Fisher Scientific
  • Merck KGaA
  • Tokyo Chemical Industry（TCI）
  • Cayman Chemical Company
  • LGC Group
  • Selleck Chemicals
  • Abcam
  • ChemFaces
  • Biosynth
  • MedChemExpress
  • ChemScene
  • Chem Impex International
  • Spectrum Chemical
  • Extrasynthese
  • Aladdin Scientific
Product Code: SMRC32269

According to Stratistics MRC, the Global Betulinic Acid Market is accounted for $0.10 billion in 2025 and is expected to reach $0.33 billion by 2032 growing at a CAGR of 17.7% during the forecast period. Betulinic acid, a natural pentacyclic triterpenoid compound found mainly in birch bark and various medicinal plants, possesses multiple therapeutic properties such as anticancer, antiviral, antibacterial, and anti-inflammatory effects. It works by triggering apoptosis in tumor cells, suppressing viral growth, and combating oxidative damage. Owing to its bioactive nature and broad pharmacological potential, betulinic acid holds significant promise for future drug research and clinical use.

Market Dynamics:

Driver:

Rising global cancer incidence

As oncology research intensifies, natural anticancer agents are gaining traction for their therapeutic potential. Betulinic acid, known for its selective cytotoxicity against tumor cells, is increasingly being explored in clinical and nutraceutical applications. Aging populations and improved diagnostic capabilities are expanding the demand for targeted cancer therapies. Pharmaceutical and nutraceutical firms are investing in plant-derived molecules to complement conventional treatments. This trend is expected to accelerate betulinic acid adoption across both preventive and therapeutic segments.

Restraint:

Limited availability of raw materials

Seasonal harvesting cycles and geographic limitations restrict access to high-yield raw materials. Sustainable sourcing remains a challenge, especially for manufacturers aiming to scale operations. Regulatory pressures around deforestation and biodiversity conservation further complicate raw material procurement. Smaller producers face cost barriers and logistical hurdles in securing reliable supply chains. These limitations may slow market expansion and increase dependency on synthetic alternatives.

Opportunity:

Advancements in synthesis/extraction technology

Green chemistry approaches and enzymatic techniques are improving yield and purity while reducing environmental impact. Researchers are developing scalable biotechnological processes to overcome raw material constraints. These innovations are lowering production costs and enabling broader commercial applications. Enhanced extraction protocols are also facilitating integration into pharmaceutical formulations and functional foods. As technology matures, it is expected to drive market growth and expand accessibility.

Threat:

Competition from synthetic substitutes

The emergence of synthetic analogs with similar pharmacological profiles poses a competitive threat to natural betulinic acid. These lab-engineered compounds often offer greater consistency, scalability, and regulatory clarity. Pharmaceutical firms may favor synthetic options due to streamlined approval pathways and cost advantages. Advances in medicinal chemistry are enabling the design of more potent derivatives that mimic betulinic acid's anticancer effects. This shift could divert investment away from natural sources and reduce market share for botanical extracts. Without clear differentiation, natural betulinic acid may struggle to maintain its position in high-value applications.

Covid-19 Impact:

The pandemic disrupted global supply chains, delaying raw material procurement and manufacturing timelines for betulinic acid. Lockdowns and labor shortages affected harvesting and processing operations, especially in forest-rich regions. However, the crisis also heightened interest in immune-supportive and antiviral compounds, indirectly benefiting demand. Research into betulinic acid's antiviral properties gained momentum, with some studies exploring its role in COVID-19 adjunct therapies. Post-pandemic strategies now emphasize supply chain resilience and diversified sourcing for botanical actives.

The natural source segment is expected to be the largest during the forecast period

The natural source segment is expected to account for the largest market share during the forecast period, due to its perceived safety, bioavailability, and consumer preference for plant-based ingredients. Betulinic acid derived from birch bark and other botanical sources is favored in nutraceuticals and cosmeceuticals for its anti-inflammatory and anticancer properties. Regulatory bodies are increasingly supporting natural compounds through clean-label initiatives and traditional medicine frameworks. Manufacturers are investing in sustainable harvesting and traceability to meet rising demand. The segment benefits from growing awareness of natural therapeutics and holistic wellness.

The nutraceutical companies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the nutraceutical companies segment is predicted to witness the highest growth rate, due to rising consumer interest in preventive health and functional supplements. These firms are incorporating betulinic acid into formulations targeting immunity, inflammation, and cancer prevention. The clean-label movement and demand for plant-derived actives are driving innovation in capsules, powders, and beverages. Strategic partnerships with botanical extractors and research institutions are accelerating product development. Regulatory support for dietary supplements is enabling faster market entry and broader distribution.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its rich biodiversity, expanding healthcare infrastructure, and strong demand for traditional medicine. Countries like China, India, and South Korea are investing in botanical research and natural product development. Government initiatives are promoting the integration of herbal compounds into mainstream healthcare and nutraceuticals. The region's manufacturing capabilities and cost advantages support large-scale production of betulinic acid. Rising cancer incidence and consumer preference for natural remedies are fueling market growth.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its robust R&D ecosystem and growing adoption of plant-based therapeutics. The U.S. and Canada are witnessing increased investment in natural oncology agents and functional ingredients. Regulatory agencies are streamlining pathways for botanical drug approvals and dietary supplements. Consumer awareness around cancer prevention and immune health is driving demand for bioactive compounds like betulinic acid. Innovation in extraction technologies and product formats is expanding market penetration.

Key players in the market

Some of the key players in Betulinic Acid Market include Thermo Fi, Merck KGa, Tokyo Che, Cayman Ch, LGC Group, Selleck Ch, Abcam, ChemFace, Biosynth, MedChem, ChemScen, Chem Imp, Spectrum, Extrasynt, and Aladdin S.

Key Developments:

In October 2025, Thermo Fisher Scientific Inc. announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance.

In October 2025, Merck has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to co-develop novel technologies that advance drug screening and discovery. The agreement unites Merck's strength in organoids and synthetic chemistry with Promega's market leading assay and reporter technologies.

Sources Covered:

  • Natural Source
  • Synthetic Source

Forms Covered:

  • Powder
  • Liquid
  • Capsules

Purities Covered:

  • >=98% Purity
  • <98% Purity

Applications Covered:

  • Pharmaceuticals
  • Cosmetics & Personal Care
  • Food & Nutraceuticals
  • Chemical & Research Uses
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Cosmetic Manufacturers
  • Research Laboratories
  • Nutraceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Betulinic Acid Market, By Source

  • 5.1 Introduction
  • 5.2 Natural Source
  • 5.3 Synthetic Source

6 Global Betulinic Acid Market, By Form

  • 6.1 Introduction
  • 6.2 Powder
  • 6.3 Liquid
  • 6.4 Capsules

7 Global Betulinic Acid Market, By Purity

  • 7.1 Introduction
  • 7.2 >=98% Purity
  • 7.3 <98% Purity

8 Global Betulinic Acid Market, By Application

  • 8.1 Introduction
  • 8.2 Pharmaceuticals
    • 8.2.1 Anti-cancer Drugs
    • 8.2.2 Anti-HIV Drugs
    • 8.2.3 Anti-inflammatory Drugs
  • 8.3 Cosmetics & Personal Care
    • 8.3.1 Anti-aging Products
    • 8.3.2 Skin Repair Formulations
  • 8.4 Food & Nutraceuticals
    • 8.4.1 Dietary Supplements
    • 8.4.2 Functional Foods
  • 8.5 Chemical & Research Uses
  • 8.6 Other Applications

9 Global Betulinic Acid Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Companies
  • 9.3 Cosmetic Manufacturers
  • 9.4 Research Laboratories
  • 9.5 Nutraceutical Companies
  • 9.6 Other End Users

10 Global Betulinic Acid Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Thermo Fisher Scientific
  • 12.2 Merck KGaA
  • 12.3 Tokyo Chemical Industry (TCI)
  • 12.4 Cayman Chemical Company
  • 12.5 LGC Group
  • 12.6 Selleck Chemicals
  • 12.7 Abcam
  • 12.8 ChemFaces
  • 12.9 Biosynth
  • 12.10 MedChemExpress
  • 12.11 ChemScene
  • 12.12 Chem Impex International
  • 12.13 Spectrum Chemical
  • 12.14 Extrasynthese
  • 12.15 Aladdin Scientific

List of Tables

  • Table 1 Global Betulinic Acid Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Betulinic Acid Market Outlook, By Source (2024-2032) ($MN)
  • Table 3 Global Betulinic Acid Market Outlook, By Natural Source (2024-2032) ($MN)
  • Table 4 Global Betulinic Acid Market Outlook, By Synthetic Source (2024-2032) ($MN)
  • Table 5 Global Betulinic Acid Market Outlook, By Form (2024-2032) ($MN)
  • Table 6 Global Betulinic Acid Market Outlook, By Powder (2024-2032) ($MN)
  • Table 7 Global Betulinic Acid Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 8 Global Betulinic Acid Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 9 Global Betulinic Acid Market Outlook, By Purity (2024-2032) ($MN)
  • Table 10 Global Betulinic Acid Market Outlook, By >=98% Purity (2024-2032) ($MN)
  • Table 11 Global Betulinic Acid Market Outlook, By <98% Purity (2024-2032) ($MN)
  • Table 12 Global Betulinic Acid Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global Betulinic Acid Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 14 Global Betulinic Acid Market Outlook, By Anti-cancer Drugs (2024-2032) ($MN)
  • Table 15 Global Betulinic Acid Market Outlook, By Anti-HIV Drugs (2024-2032) ($MN)
  • Table 16 Global Betulinic Acid Market Outlook, By Anti-inflammatory Drugs (2024-2032) ($MN)
  • Table 17 Global Betulinic Acid Market Outlook, By Cosmetics & Personal Care (2024-2032) ($MN)
  • Table 18 Global Betulinic Acid Market Outlook, By Anti-aging Products (2024-2032) ($MN)
  • Table 19 Global Betulinic Acid Market Outlook, By Skin Repair Formulations (2024-2032) ($MN)
  • Table 20 Global Betulinic Acid Market Outlook, By Food & Nutraceuticals (2024-2032) ($MN)
  • Table 21 Global Betulinic Acid Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 22 Global Betulinic Acid Market Outlook, By Functional Foods (2024-2032) ($MN)
  • Table 23 Global Betulinic Acid Market Outlook, By Chemical & Research Uses (2024-2032) ($MN)
  • Table 24 Global Betulinic Acid Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 25 Global Betulinic Acid Market Outlook, By End User (2024-2032) ($MN)
  • Table 26 Global Betulinic Acid Market Outlook, By Pharmaceutical Companies (2024-2032) ($MN)
  • Table 27 Global Betulinic Acid Market Outlook, By Cosmetic Manufacturers (2024-2032) ($MN)
  • Table 28 Global Betulinic Acid Market Outlook, By Research Laboratories (2024-2032) ($MN)
  • Table 29 Global Betulinic Acid Market Outlook, By Nutraceutical Companies (2024-2032) ($MN)
  • Table 30 Global Betulinic Acid Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.